Edition:
United States

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

32.90SEK
6:35am EDT
Change (% chg)

0.00kr (+0.00%)
Prev Close
32.90kr
Open
32.70kr
Day's High
32.90kr
Day's Low
32.25kr
Volume
25,736
Avg. Vol
56,563
52-wk High
81.75kr
52-wk Low
32.10kr

Chart for

About

Medivir AB is a Sweden-based pharmaceutical company engaged in the research, development and sale of drugs against widespread diseases, with protease and polymerase as its target enzymes. The Company’s research focuses on developing small molecule pharmaceuticals, primarily against infectious diseases caused by viruses. The... (more)

Overall

Beta: 1.14
Market Cap(Mil.): kr807.57
Shares Outstanding(Mil.): 24.29
Dividend: --
Yield (%): --

Financials

  MVIRb.ST Industry Sector
P/E (TTM): -- 212.74 32.86
EPS (TTM): -16.09 -- --
ROI: -49.14 -3.73 13.13
ROE: -50.58 -5.79 15.07

BRIEF-Medivir Q1 operating loss narrows

* MEDIVIR Q1 NET TURNOVER TOTALED SEK 4.5 MILLION (17.8 M)OF WHICH SEK 4.5 MILLION (13.7 M) COMPRISED THE FIRST QUARTER’S ROYALTIES

Apr 27 2018

BRIEF-Medivir completes directed issue of around 155 mln SEK

* MEDIVIR HAS COMPLETED A DIRECTED SHARE ISSUE OF APPROXIMATELY 155 MSEK

Feb 02 2018

BRIEF-Medivir Intends To Make A Directed Share Issue

* MEDIVIR - ‍MEDIVIR IS IN DISCUSSIONS WITH FDA ON DESIGN OF PIVOTAL PHASE III CTCL STUDY FOR REMETINOSTAT​

Feb 01 2018

Earnings vs. Estimates